Capacity investment more than street valuations
Among the most dislocated Asian non-ferrous stocks: Hindalco is the second worst-performing stock in our Asia-Pacific non-ferrous coverage universe on a 12-month basis, down 29%. Consensus has lowered FY14 Ebitda estimates by 10% during this time-frame.
More upside than downside: In our base case scenario, we find investors almost paying nothing for the $4 bn spent on the new capacities. If Novelis? Ebitda grows to $1.3 bn in FY16, even after valuing CWIP (construction work in process) at zero, the stock offers a 24% difference to the current share price. In a worst case scenario, if Novelis? Ebitda does not grow and CWIP is valued at zero, we believe there is a c35% negative difference to the current share price. However, the worst case scenario is fraught with upside risks. In a best case scenario, assuming investors value CWIP at 25% of the amount invested and Novelis? Ebitda reaches $1.3bn in FY16, we see a 66% difference to the current share price. Overall, we see more upside than downside risks.
We lower our FY14-15 Ebitda estimates by 13% and 11%, factoring in lower profitability at the standalone business due to a weak aluminium price outlook. We derive a target price of R120/share and continue to rate Hindalco Overweight. Our target price implies a potential return of c34%.
Lower-than-expected aluminium prices and copper TC/RCs (treatment & refining charges), coupled with delays in project execution at Mahan Aluminium and Utkal Alumina, are the key downside risks.
HSBC